| 1 |
Robert A. Vito |
Matscitechno Licensing |
10 |
| 2 |
David T. Beatson |
Kulicke & Soffa Investments |
4 |
| 3 |
James H. Lipscomb |
Gen-Probe Incorporated |
2 |
| 3 |
Robert E. Bridges |
Faro Technologies |
2 |
| 3 |
Stephen H. Harris |
Arco Chemical Technology |
2 |
| 3 |
Lucy Clarkson |
E.I. Du Pont De Nemours And |
2 |
| #7 |
James Kimmel |
Meta |
1 |
| #7 |
Alex Sergey Ionkin |
E.I. Du Pont De Nemours And |
1 |
| #7 |
Mark Harmer |
E.I. Du Pont De Nemours And |
1 |
| #7 |
Andrew P. Combs |
Incyte |
1 |
| #7 |
Paul Yaniga |
— |
1 |
| #7 |
Manirpallam Appadorai Subramanian |
E.I. Du Pont De Nemours And |
1 |
| #7 |
Ardeshir Faghri |
— |
1 |
| #7 |
Francis R. Salemme |
3-Dimensional Pharmaceuticals |
1 |
| #7 |
Jeffrey H. Peltier |
Betzdearborn |
1 |
| #7 |
Howard Tennent |
Hyperion Catalysis International |
1 |
| #7 |
Arthur W. Sleight |
E.I. Du Pont De Nemours And |
1 |
| #7 |
Stephen M. Foster |
Pactiv |
1 |
| #7 |
Ying Kwong Yee |
Eli Lilly |
1 |
| #7 |
Vinci Martinez Felix |
E.I. Du Pont De Nemours And |
1 |
| #7 |
Thomas R. Fields |
Rexam Industries |
1 |
| #7 |
Craig Novak |
Unique Industries |
1 |
| #7 |
Namit Ghildyal |
Zeneca Limited |
1 |
| #7 |
Munirpallam A. Subramanian |
E.I. Du Pont De Nemours And |
1 |
| #7 |
Daniel D. Friel, Jr. |
Edgecraft |
1 |
| #7 |
Argyrios G. Arvanitis |
Incyte |
1 |
| #7 |
Donald Bernard Bivens |
E.I. Du Pont De Nemours And |
1 |
| #7 |
Marc D. Pevar |
— |
1 |
| #7 |
Richard Alan Hall |
IBM |
1 |